Free Trial

TScan Therapeutics (TCRX) Institutional Ownership

-0.29 (-3.33%)
(As of 05/24/2024 ET)

Institutional Ownership Changes (13F Filings) for TScan Therapeutics (NASDAQ:TCRX)

Institutional Ownership
Number of
Institutional Buyers
(last 12 months)
Institutional Inflows
(last 12 months)
Number of
Institutional Sellers
(last 12 months)
Institutional Outflows
(last 12 months)
Get TCRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TCRX Institutional Buying and Selling by Quarter

TScan Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024 Vanguard Group Inc.1,808,152$14.36M0.0%+1.1%3.776%
5/10/2024 Tocqueville Asset Management L.P.212,200$1.69M0.0%N/A0.443%
4/17/2024 Cannon Global Investment Management LLC17,500$139K0.4%N/A0.037%
2/14/2024 Pale Fire Capital SE21,573$126K0.0%+30.2%0.045%
2/12/2024 Letko Brosseau & Associates Inc.20,700$121K0.0%-36.1%0.043%
1/31/2024 abrdn plc200,000$1.17M0.0%N/A0.418%
11/14/2023 Pale Fire Capital SE16,575$42K0.0%N/A0.035%
11/9/2023 Letko Brosseau & Associates Inc.32,400$83K0.0%N/A0.068%
8/15/2023 BVF Inc. IL2,989,474$7.47M0.2%N/A12.338%
8/10/2023 Monashee Investment Management LLC400,000$1M0.2%N/A1.651%
7/26/2023 Privium Fund Management B.V.15,825$40K0.0%N/A0.065%
5/10/2023 Simplify Asset Management Inc.546,916$1.15M0.2%N/A2.257%
2/15/2023 Tang Capital Management LLC514,655$798K0.1%-7.8%2.137%
11/16/2022 Alphabet Inc.1,077,080$3.29M0.2%N/A4.482%
11/15/2022 Tang Capital Management LLC557,915$1.70M0.2%-25.4%2.322%
11/4/2022 Prudential Financial Inc.11,000$34K0.0%N/A0.046%
11/1/2022 Privium Fund Management UK Ltd15,825$48K0.1%N/A0.066%
5/17/2022 RA Capital Management L.P.1,021,764$2.86M0.1%-18.6%4.299%
5/17/2022 Hhlr Advisors LTD.669,513$1.88M0.0%-47.8%2.817%
4/26/2022 Marquette Asset Management LLC28,895$81K0.0%+33.7%0.122%
2/15/2022 Deer Management Co. LLC1,245,505$5.61M0.1%N/A5.240%
2/15/2022 Adage Capital Partners GP L.L.C.550,000$2.48M0.0%+10.8%2.314%
1/19/2022 Marquette Asset Management LLC21,618$97K0.0%N/A0.091%
11/16/2021 Schonfeld Strategic Advisors LLC22,200$185K0.0%N/A0.093%
11/16/2021 Wellington Management Group LLP139,566$1.16M0.0%N/A0.582%
11/15/2021 RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238%
11/15/2021 Caas Capital Management LP75,000$626K0.0%N/A0.313%
11/12/2021 DC Investments Management LLC35,563$297K0.6%N/A0.148%
11/12/2021 DC Funds LP630,000$5.25M20.6%N/A2.629%
11/9/2021 BlackRock Inc.1,500,577$12.52M0.0%N/A6.261%
11/9/2021 Monashee Investment Management LLC100,000$834K0.2%N/A0.417%
(Data available from 1/1/2016 forward)

TCRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TCRX shares?

During the previous two years, 14 institutional investors and hedge funds held shares of TScan Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($14.36M), BVF Inc. IL ($7.47M), Alphabet Inc. ($3.29M), Tocqueville Asset Management L.P. ($1.69M), abrdn plc ($1.17M), Simplify Asset Management Inc. ($1.15M), and Monashee Investment Management LLC ($1M).Learn more on TCRX's institutional investors.

What percentage of TScan Therapeutics stock is owned by institutional investors?

82.83% of TScan Therapeutics stock is owned by institutional investors. Learn more on TCRX's institutional investor holdings.

Which institutional investors have been buying TScan Therapeutics stock?

Of the 13 institutional investors that purchased TScan Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.99M), Alphabet Inc. ($1.08M), Simplify Asset Management Inc. ($546.92K), Monashee Investment Management LLC ($400K), Tocqueville Asset Management L.P. ($212.20K), abrdn plc ($200K), and Letko Brosseau & Associates Inc. ($32.40K).

How much institutional buying is happening at TScan Therapeutics?

Institutional investors have bought a total of 5,559,793 shares in the last 24 months. This purchase volume represents approximately $16.33M in transactions.

Which TScan Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold TScan Therapeutics stock in the last 24 months: Tang Capital Management LLC ($233.15K), and Letko Brosseau & Associates Inc. ($11.70K).

How much institutional selling is happening at TScan Therapeutics?

Institutional investors have sold a total of 244,845 shares in the last 24 months. This volume of shares sold represents approximately $714.41K in transactions.

This page (NASDAQ:TCRX) was last updated on 5/26/2024 by Staff

From Our Partners